These highlights do not include all the information needed to use NESINA safely and effectively. See full prescribing information for NESINA.
NESINA (alogliptin) tablets
Initial U.S. Approval: 2013
INDICATIONS AND USAGE
NESINA is a dipeptidyl peptidase-4 (DPP-4) inhibitor indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. (1.1, 14)
Limitation of Use: Not for treatment of type 1 diabetes or diabetic ketoacidosis. (1.2)
DOSAGE AND ADMINISTRATION
-
•
-
The recommended dose in patients with normal renal function or mild renal impairment is 25 mg once daily. ( 2.1)
-
•
-
Can be taken with or without food. ( 2.1)
-
•
-
Adjust dose if moderate or severe renal impairment or end-stage renal disease (ESRD). ( 2.2)
Degree of Renal Impairment
|
Creatinine Clearance (mL/min)
|
以下是“全球医药”详细资料 |
|
|
|